JP2022502416A5 - - Google Patents
Info
- Publication number
- JP2022502416A5 JP2022502416A5 JP2021517009A JP2021517009A JP2022502416A5 JP 2022502416 A5 JP2022502416 A5 JP 2022502416A5 JP 2021517009 A JP2021517009 A JP 2021517009A JP 2021517009 A JP2021517009 A JP 2021517009A JP 2022502416 A5 JP2022502416 A5 JP 2022502416A5
- Authority
- JP
- Japan
- Prior art keywords
- mhc
- score
- neoepitopes
- minimum
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18197172 | 2018-09-27 | ||
| EP18197172.2 | 2018-09-27 | ||
| PCT/EP2019/076210 WO2020065023A1 (en) | 2018-09-27 | 2019-09-27 | Method for selecting neoepitopes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022502416A JP2022502416A (ja) | 2022-01-11 |
| JP2022502416A5 true JP2022502416A5 (https=) | 2022-09-27 |
| JP7585195B2 JP7585195B2 (ja) | 2024-11-18 |
Family
ID=63794302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517009A Active JP7585195B2 (ja) | 2018-09-27 | 2019-09-27 | ネオエピトープを選択する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12462898B2 (https=) |
| EP (1) | EP3856957A1 (https=) |
| JP (1) | JP7585195B2 (https=) |
| KR (1) | KR102902460B1 (https=) |
| CN (1) | CN112771214B (https=) |
| AU (1) | AU2019346023B2 (https=) |
| BR (1) | BR112021005702A8 (https=) |
| CA (1) | CA3111903A1 (https=) |
| IL (1) | IL281771B2 (https=) |
| MX (1) | MX2021003654A (https=) |
| SG (1) | SG11202101965QA (https=) |
| WO (1) | WO2020065023A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020221783A1 (en) * | 2019-04-29 | 2020-11-05 | Vaccibody As | Methods for pre-selection of neoepitopes |
| CN116802738A (zh) * | 2020-11-06 | 2023-09-22 | 亚马逊科技公司 | 为个体化癌症疫苗选择新抗原 |
| GB202102606D0 (en) * | 2021-02-24 | 2021-04-07 | Univ Oxford Innovation Ltd | Treatment of ovarian cancer minimal residual disease |
| KR20230164118A (ko) | 2021-03-26 | 2023-12-01 | 니코데 테라퓨틱스 에이에스에이 | 암 치료를 위한 치료 조합 |
| BR112023023260A2 (pt) | 2021-05-10 | 2024-01-30 | Nykode Therapeutics ASA | Vetor, métodos para produzir um vetor e para tratar um sujeito tendo uma doença ou uma doença infecciosa, célula hospedeira, e, composição farmacêutica |
| WO2022238381A2 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunotherapy constructs for treatment of disease |
| WO2023244997A1 (en) * | 2022-06-13 | 2023-12-21 | The University Of North Carolina At Chapel Hill | Compositions and methods for inducing anticancer immunity |
| WO2024092025A1 (en) | 2022-10-25 | 2024-05-02 | Nykode Therapeutics ASA | Constructs and their use |
| KR102857635B1 (ko) * | 2022-11-08 | 2025-09-10 | 인바이츠지노믹스 주식회사 | 면역원성이 높은 유사체를 디자인하는 방법 및 이를 이용한 장치 |
| WO2024100196A1 (en) | 2022-11-09 | 2024-05-16 | Nykode Therapeutics ASA | Co-expression of constructs and polypeptides |
| WO2024216073A1 (en) * | 2023-04-14 | 2024-10-17 | The Trustees Of Columbia University In The City Of New York | Engineered microbes comprising tumor neoantigen vectors for cancer immunotherapy |
| US20250232833A1 (en) * | 2024-01-13 | 2025-07-17 | Noergaard Anders Kaare | Cyclin D1 Based Cancer Vaccine |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2569633B1 (en) | 2010-05-14 | 2016-02-10 | The General Hospital Corporation | Compositions and methods of identifying tumor specific neoantigens |
| PL3892295T3 (pl) | 2011-05-24 | 2023-07-24 | BioNTech SE | Zindywidualizowane szczepionki przeciwnowotworowe |
| EP3417874B1 (en) | 2012-11-28 | 2024-09-11 | BioNTech SE | Individualized vaccines for cancer |
| EP2983702A2 (en) | 2013-04-07 | 2016-02-17 | The Broad Institute, Inc. | Compositions and methods for personalized neoplasia vaccines |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| US20160367651A1 (en) | 2013-10-01 | 2016-12-22 | Mie University | T cell inducing vaccine containing an interepitope sequence that promotes antigen presentation |
| WO2016015095A1 (en) | 2014-07-31 | 2016-02-04 | The University Of Western Australia | A method for the identification of immunotherapy-drug combinations using a network approach |
| WO2016040900A1 (en) | 2014-09-14 | 2016-03-17 | Washington University | Personalized cancer vaccines and methods therefor |
| US10317402B2 (en) | 2014-12-03 | 2019-06-11 | Verik Bio, Inc. | Identification, selection and use of high curative potential T cell epitopes |
| WO2016128060A1 (en) | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| BR112017022845A2 (pt) * | 2015-04-23 | 2018-07-17 | Nantomics, Llc | neoepítopos de câncer |
| EA201792501A1 (ru) * | 2015-05-13 | 2018-10-31 | Эйдженус Инк. | Вакцины для лечения и профилактики рака |
| EP3323070B1 (en) * | 2015-07-14 | 2024-05-08 | Personal Genome Diagnostics Inc. | Neoantigen analysis |
| ES2970865T3 (es) | 2015-12-16 | 2024-05-31 | Gritstone Bio Inc | Identificación, fabricación y uso de neoantígenos |
| WO2018136664A1 (en) | 2017-01-18 | 2018-07-26 | Ichan School Of Medicine At Mount Sinai | Neoantigens and uses thereof for treating cancer |
| EP3678699A1 (en) | 2017-09-07 | 2020-07-15 | University Of Oslo | Vaccine molecules |
-
2019
- 2019-09-27 MX MX2021003654A patent/MX2021003654A/es unknown
- 2019-09-27 SG SG11202101965QA patent/SG11202101965QA/en unknown
- 2019-09-27 IL IL281771A patent/IL281771B2/en unknown
- 2019-09-27 US US17/279,946 patent/US12462898B2/en active Active
- 2019-09-27 EP EP19773458.5A patent/EP3856957A1/en active Pending
- 2019-09-27 JP JP2021517009A patent/JP7585195B2/ja active Active
- 2019-09-27 KR KR1020217012734A patent/KR102902460B1/ko active Active
- 2019-09-27 BR BR112021005702A patent/BR112021005702A8/pt unknown
- 2019-09-27 CA CA3111903A patent/CA3111903A1/en active Pending
- 2019-09-27 WO PCT/EP2019/076210 patent/WO2020065023A1/en not_active Ceased
- 2019-09-27 CN CN201980063254.9A patent/CN112771214B/zh active Active
- 2019-09-27 AU AU2019346023A patent/AU2019346023B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022502416A5 (https=) | ||
| Clark et al. | Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data | |
| Adegunsoye et al. | Genetics and genomics of pulmonary fibrosis: charting the molecular landscape and shaping precision medicine | |
| Weiss et al. | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved | |
| Goldfeder et al. | Human genome sequencing at the population scale: a primer on high-throughput DNA sequencing and analysis | |
| King et al. | High-quality and high-throughput massively parallel sequencing of the human mitochondrial genome using the Illumina MiSeq | |
| Moll et al. | The human keratins: biology and pathology | |
| Nakamura et al. | Differential effects of fingolimod on B-cell populations in multiple sclerosis | |
| JP2018524008A (ja) | ネオアンチゲン分析 | |
| Wong et al. | Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma | |
| Blenk et al. | Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis | |
| JP2006514554A (ja) | 腎細胞癌および他の固形腫瘍の診断法 | |
| TWI758298B (zh) | 利用單步驟逆轉錄模板置換pcr之t細胞受體及b細胞受體多樣性解析系統 | |
| Ward et al. | Effects of spaceflight on the immunoglobulin repertoire of unimmunized C57BL/6 mice | |
| Liu et al. | Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication | |
| Holm et al. | Polymorphisms in the SEEK1 and SPR1 genes on 6p21. 3 associate with psoriasis in the Swedish population | |
| CN111133115A (zh) | 用于其肿瘤携带高过客基因突变负荷的患者的免疫治疗方法 | |
| JP2023540904A (ja) | タンパク質および核酸をアッセイするための組成物および方法 | |
| Cari et al. | Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis | |
| Grinev et al. | Decoding of exon splicing patterns in the human RUNX1–RUNX1T1 fusion gene | |
| EP3658689A1 (en) | A method for non-invasive prenatal detection of fetal chromosome aneuploidy from maternal blood based on bayesian network | |
| Martino et al. | Refining high-risk multiple myeloma: advancements in genomic, clinical, and prognostic criteria | |
| Yu et al. | Outliers in RhD membrane integration are explained by variant RH haplotypes | |
| Chen et al. | Quantified CIN score from cell-free DNA as a novel noninvasive predictor of survival in patients with spinal metastasis | |
| CN114530202A (zh) | 鉴定抗原特异性tcr或bcr的方法及应用 |